Matthew Gregory Cohen
CIK: 0002141314
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Director
Discretionary Trading P&L
Holdings
About Cohen Matthew Gregory
Cohen Matthew Gregory (SEC CIK 0002141314) files insider reports with the SEC as Director of ARROWHEAD PHARMACEUTICALS, INC. (ARWR).
Signal8 holds 2 ownership filings by Cohen Matthew Gregory (1 Form 3, 1 Form 4), filed on Jun 17, 2026. Those filings report 1 transaction, the latest on Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cohen Matthew Gregory's filings is in PASADENA, CA.
Recent filings by Cohen Matthew Gregory
- Jun 15, 2026: Grant or award of ARWR shares (Form 4, code A).
Other insiders filing for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
- OLUKOTUN ADEOYE Y, Director
- PERRY MICHAEL S, Director
- Lu Hongbo, Director
- Apel Daniel Joseph, Chief Financial Officer
- Hamilton James C, Chief Medical Officer
- O'Brien Patrick, COO